|
Volumn 190, Issue 1, 1996, Pages 109-142
|
Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis;Administration par aérosol d'un adénovirus recombinant déficient pour la réplication contenant cADN-CFTR humain normal dans le tractus respiratoire de patients atteints de mucoviscidose.
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
CFTR PROTEIN, HUMAN;
RECOMBINANT DNA;
TRANSMEMBRANE CONDUCTANCE REGULATOR;
ADENOVIRUS;
ADOLESCENT;
ADULT;
AEROSOL;
ANIMAL;
ARTICLE;
CLINICAL TRIAL;
CYSTIC FIBROSIS;
DEFECTIVE VIRUS;
DRUG TOLERANCE;
GENE THERAPY;
GENE TRANSFER;
GENE VECTOR;
GENETIC RECOMBINATION;
GENETICS;
HUMAN;
METHODOLOGY;
PHASE 1 CLINICAL TRIAL;
RELATIVE BIOLOGIC EFFECTIVENESS;
RESPIRATORY SYSTEM;
VIROLOGY;
ADENOVIRIDAE;
ADOLESCENT;
ADULT;
AEROSOLS;
ANIMALS;
CYSTIC FIBROSIS;
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;
DEFECTIVE VIRUSES;
DNA, RECOMBINANT;
DRUG TOLERANCE;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
GENETIC VECTORS;
HUMANS;
RECOMBINATION, GENETIC;
RELATIVE BIOLOGICAL EFFECTIVENESS;
RESPIRATORY SYSTEM;
|
EID: 0029680859
PISSN: 00379026
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|